TickerFactsScreenerDevelopers

Alzamend Neuro, Inc. (ALZN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$2.35M2021: -$2.71M2022: -$6.61M2023: -$8.92M2024: -$8.27M2025: -$6.57M2026: -$8.07M-$8.07M
2020Operating Cash Flow (USD)2026
Fiscal YearOperating Cash FlowChange YoY
2026-$8.07M-22.8%
2025-$6.57M+20.6%
2024-$8.27M+7.3%
2023-$8.92M-34.9%
2022-$6.61M-143.9%
2021-$2.71M-15.6%
2020-$2.35M—